Ocumension Therapeutics (1477.HK)

HKD 4.63

(-3.54%)

Total Liabilities Summary of Ocumension Therapeutics

Ocumension Therapeutics's latest annual total liabilities in 2023 was 351.03 Million CNY , up 18.98% from previous year.
Ocumension Therapeutics's latest quarterly total liabilities in 2023 FY was 351.03 Million CNY , up 18.98% from previous quarter.
Ocumension Therapeutics reported annual total liabilities of 295.03 Million CNY in 2022, up 32.37% from previous year.
Ocumension Therapeutics reported annual total liabilities of 222.88 Million CNY in 2021, up 129.22% from previous year.
Ocumension Therapeutics reported quarterly total liabilities of 351.03 Million CNY for 2023 Q4, down 0.0% from previous quarter.
Ocumension Therapeutics reported quarterly total liabilities of 255.19 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Ocumension Therapeutics (2023 - 2018)

Historical Annual Total Liabilities of Ocumension Therapeutics (2023 - 2018)

Year	Total Liabilities	Total Liabilities Growth
2023	351.03 Million CNY	18.98%
2022	295.03 Million CNY	32.37%
2021	222.88 Million CNY	129.22%
2020	97.23 Million CNY	-97.1%
2019	3.35 Billion CNY	285.15%
2018	871.92 Million CNY	0.0%

Year	Total Liabilities	Total Liabilities Growth
2023 Q1	255.19 Million CNY	-13.5%
2023 Q4	351.03 Million CNY	0.0%
2023 Q2	255.19 Million CNY	0.0%
2023 Q3	351.03 Million CNY	37.55%
2023 FY	351.03 Million CNY	18.98%
2022 Q1	314.64 Million CNY	41.17%
2022 Q4	295.03 Million CNY	0.0%
2022 Q3	295.03 Million CNY	-6.23%
2022 Q2	314.64 Million CNY	0.0%
2022 FY	295.03 Million CNY	32.37%
2021 Q1	130.21 Million CNY	33.92%
2021 FY	222.88 Million CNY	129.22%
2021 Q3	222.88 Million CNY	71.16%
2021 Q2	130.21 Million CNY	0.0%
2021 Q4	222.88 Million CNY	0.0%
2020 Q3	97.23 Million CNY	-98.01%
2020 Q4	97.23 Million CNY	0.0%
2020 FY	97.23 Million CNY	-97.1%
2020 Q1	4.88 Billion CNY	45.53%
2020 Q2	4.88 Billion CNY	0.0%
2019 Q1	- CNY	0.0%
2019 Q4	3.35 Billion CNY	0.0%
2019 Q3	3.35 Billion CNY	0.0%
2019 FY	3.35 Billion CNY	285.15%
2018 FY	871.92 Million CNY	0.0%

Peer Total Liabilities Comparison of Ocumension Therapeutics

Name	Total Liabilities	Total Liabilities Difference
Uni-Bio Science Group Limited	152.81 Million HKD	-129.705%
CK Life Sciences Int'l., (Holdings) Inc.	7.05 Billion HKD	95.027%